Cellomics and GE Healthcare Collaborate To Provide Faster and More Effective Cellular Screening
Software Development and Commercialization Agreement Offers Informatics Solution for High Content Screening
Pittsburgh. Cellomics, Inc. and GE Healthcare (a combination of the former Amersham and GE Medical Systems) announced a software development and commercialization agreement aimed at facilitating faster and more efficient drug development. Under the terms of the agreement, the two companies will collaborate to develop and market an interface that permits High Content Screening (HCS) analysis utilizing both GE Healthcare's sub-cellular imaging instruments and Cellomics' high content informatics (HCi*) platform.
Under the agreement, Cellomics will develop and sell software that allows data and images generated by GE Healthcare's IN Cell Analyzer 3000 and IN Cell Analyzer 1000 sub-cellular imaging systems to be extracted and interrogated by Cellomics® Store and vHCS* Discovery ToolBox, key components of Cellomics' HCi platform. When used with the IN Cell Analyzer 3000 and IN Cell Analyzer 1000 systems, the software will enable researchers to easily store, mine and interpret data, and so make faster and more informed decisions in their drug development process.
"This collaboration with Cellomics supports GE Healthcare's strategy of helping customers improve efficiencies in gathering, analyzing, and understanding complex drug development information," said Michael Evans, vice president of marketing and strategy, Discovery Systems, GE Healthcare. "Aided by Cellomics' informatics software, users of our IN Cell Analyzer 3000 and IN Cell Analyzer 1000 systems will be able to mine and interpret data more easily."
"Our customers have found high value by utilizing our proprietary HCi solutions for the management and analysis of their HCS data," commented Daniel J. Calvo, president and CEO of Cellomics. "These tools are vital to the success of HCS programs in both drug discovery and basic life science research. We are pleased that we will be able to combine our informatics solution expertise with GE Healthcare's cellular analysis products to drive towards the ultimate goal of cutting drug development time."
Organizations
Other news from the department business & finance
These products might interest you

Limsophy by AAC Infotray
Optimise your laboratory processes with Limsophy LIMS
Seamless integration and process optimisation in laboratory data management

ERP-Software GUS-OS Suite by GUS
Holistic ERP solution for companies in the process industry
Integrate all departments for seamless collaboration

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.